A4 HEALTH LIMITED
Opportunity 71/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Deleverage or restructure. Leverage at 100% of assets — consider sale of non-core assets or equity injection. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Total assets | £210.7k | £268.3k |
| Current assets | £170.5k | £212.8k |
| Net assets | £209.6k | £250.3k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 6 officers
- • 4 persons-with-significant-control
- • 1 confirmation-statement
Corporate timeline (24 events)Click to expand
- 2026-01-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-12-05📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-05📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-04📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-04📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-04📄change-person-secretary-company-with-change-dateofficers · CH03
- 2025-12-04📄change-person-secretary-company-with-change-dateofficers · CH03
- 2025-12-04📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-04📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-04📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-04📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-01-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-11-07📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-01-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-01-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-08📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-02-04✏️certificate-change-of-name-companychange-of-name · CERTNM
- 2022-02-02📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-01-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-04-06🏢Company incorporatedAs A4 HEALTH LIMITED
- 2018-04-06➕DIXIT, Anindya, Dr appointedsecretary
- 2018-04-06➕GULATI, Aashish, Dr appointedsecretary
- 2018-04-06➕DIXIT, Anindya, Dr appointeddirector
- 2018-04-06➕GULATI, Aashish, Dr appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Anindya Dixit Individual · English · DOB 03/1981 · age 45 | — | — | sig. influencesignificant influence | 06/04/2018 |
Dr Aashish Gulati Individual · English · DOB 05/1976 · age 50 | — | — | sig. influencesignificant influence | 06/04/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · B postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 7SVASS B LTD→ 14846065 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| A A NAILS LIMITED→ 12190383 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| A&A ORTHOPAEDIC SERVICES LTD→ 14278939 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| A1 ENDOSCOPY LTD→ 09811164 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| A1 KASH CARING LIMITED→ 15243099 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| A1 OPTICAL LTD→ 13642380 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| A1 SUPPORT LIMITED→ 08172658 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| A2 HEALTHCARE SOLUTIONS LIMITED→ 15431457 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| A2Z HEALTHCARE (UK) LIMITED→ 06569843 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| A2Z HOUSING LIMITED→ 16868691 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| A3J SMILES LTD→ 15770459 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| A87 LIMITED→ 16694439 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 0 resigned)
Click a director name to see their full track record across all companies.